Abstract
To record every patient with proved colorectal adenocarcinoma presenting from a defined population over two years in 1968-9 and during 1980-2, and to compare treatment and outcome over seven years. Retrospective in 1968-9 and prospective in 1980-2. Aberdeen general hospitals. Every patient presenting to the four general surgical units with histological proof of colorectal adenocarcinoma. On average, one new patient presented each week per 100,000 population. The proportion of patients aged 65 and over rose from 67% to 71%. An operation was performed on 385 patients in 1968-9 and on 399 during 1980-2. At laparotomy the proportion of patients who seemed to be curable and had a radical operation rose slightly, from 56% to 61%, and operative mortality fell from 9% to 5%. In all there were 421 survivors of curative surgery, and seven years later three quarters were either alive (51%) or had died without recurrence (25%). In both studies some 40% of patients were considered incurable when they presented, but the number who had a palliative resection rose from 59% to 85%. The contribution of radical surgery to the treatment of colorectal adenocarcinoma is substantial, with three quarters of patients so treated showing no evidence of recurrence after seven years. Operative mortality in an elderly population is now low, and improvement in late outcome is more likely to come from developments in adjuvant therapy than in operative technique. A continuing problem is that 40% of patients are not curable when they present, although palliative resection can now be offered to over 80%.
MeSH Terms
Adenocarcinoma/mortality,surgery
Aged
Colonic Neoplasms/mortality,surgery
Female
Humans
Male
Middle Aged
Prognosis
Prospective Studies
Rectal Neoplasms/mortality,surgery
Retrospective Studies
Scotland/epidemiology
Time Factors
Treatment Outcome
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Gordon N L
Department of Medicine, University of Aberdeen.
Dawson A A
Bennett B
Innes G
Eremin O
Jones P F
References (16)
16 references, click to expand
-
Outcome in colorectal carcinoma: seven-year study of a population.
Br Med J. 1980 Feb 16;280(6212):431-5
PMID: 7370523
-
Trends in right and left-sided colon cancer.
Dis Colon Rectum. 1983 Jun;26(6):393-8
PMID: 6851801
-
A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.
Br J Surg. 1985 May;72(5):359-63
PMID: 3888335
-
Occult hepatic metastases in colorectal carcinoma.
Br J Surg. 1986 Sep;73(9):732-5
PMID: 3756437
-
Growth rate of hepatic metastases in colorectal carcinoma.
Br J Surg. 1988 Jul;75(7):641-4
PMID: 3416116
-
Operative mortality rate and surgery for colorectal cancer.
Br J Surg. 1988 Jul;75(7):645-7
PMID: 3416117
-
Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Lancet. 1989 Jul 1;2(8653):1-7
PMID: 2567792
-
Vascularization of small liver metastases.
Br J Surg. 1989 Jun;76(6):545-8
PMID: 2474356
-
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
N Engl J Med. 1990 Feb 8;322(6):352-8
PMID: 2300087
-
Colorectal cancer in a small rural hospital.
Am J Surg. 1990 Mar;159(3):277-80; discussion 281
PMID: 2305933
-
Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up.
Br J Surg. 1990 Mar;77(3):280-2
PMID: 1691033
-
AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.
Br J Cancer. 1991 Jun;63(6):841-5
PMID: 2069842
-
Management variability in surgery for colorectal emergencies.
Br J Surg. 1992 Mar;79(3):206-10
PMID: 1555084
-
Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.
Lancet. 1992 Aug 29;340(8818):502-6
PMID: 1354275
-
Changing site distribution of colorectal cancer.
BMJ. 1992 Jul 18;305(6846):158
PMID: 1515832
-
Mesorectal excision for rectal cancer.
Lancet. 1993 Feb 20;341(8843):471-2
PMID: 8094497